KUBTEC Medical Imaging’s Post

Elevated serum EV-MDM2 levels show potential as a biomarker for detecting recurrence in retroperitoneal liposarcoma (RLS). Analysis reveals significantly higher EV-MDM2 in RLS patients vs. controls and notable decreases post-surgery. During follow-up, increases in EV-MDM2 correlate with recurrent disease on CT scans. This biomarker could fill a critical gap in early detection and surveillance, guiding treatment decisions for RLS. #CancerResearch #Biomarkers #Oncology #SurgicalOncology

Gentle on you, tough on tumors. Apollo Hospitals Bangalore’s CyberKnife provides precision treatment for diverse conditions, including lung, spine, liver, kidney, gynecology, prostate, intracranial, head and neck, breast, and pancreas. Experience advanced, non-invasive cancer care today. #CyberKnife #CancerTreatment #ApolloHospitals #NonInvasive #LungCancer #SpineCare #LiverHealth #KidneyCare #Gynecology #ProstateHealth #HeadAndNeckCancer #BreastCancer #PancreaticCancer #PrecisionTreatment #Oncology #AdvancedHealthcare #CancerAwareness

For endometrial biopsies, look no further than these MedGyn products! https://lnkd.in/gNMDvEMr #endometrialbiopsy #obgyn #obgyndoctor #medical #medicalinstruments #gynecology #oncology

The importance of patient selection criteria in treating advanced urothelial carcinoma - David J. Benjamin https://lnkd.in/d3Fm7G2z European Urology Oncology Arash Rezazadeh #Cancer #Carcinoma #UrothelialCarcinoma #CancerPatient #Medicine #CancerTreatment #Medicine #Health #Oncology #OncoDaily

It is important to reduce the burden of cancer in children and improve outcomes with a focus on timely diagnosis and effective treatment plan. In addition to chemotherapy; surgery, radiation therapy, targeted therapy and immunotherapy are combination of cancer treatment approaches.If diagnosed early majority of childhood cancers can be cured for ever #childhoodcancer #chemotherapy #pediatriconcology #CancerAwareness #cancertreatment #leukemia #Lymphomas #SolidTumors #ChemotherapySupport #newagechemo

A comprehensive meta-analysis, recently published in BMC Cancer, identifies crucial prognostic factors associated with early recurrence after liver resection for colorectal liver metastases. The study analyzed data from 24 investigations with 12705 patients, focusing on recurrence within 6 months post-surgery. High-quality evidence suggests that tumor differentiation, the extent of liver involvement, surgical margins, and postoperative complications significantly impact recurrence risks. Additionally, carcinoembryonic antigen and lymph node metastases are highlighted as key risk factors, stressing the importance of thorough monitoring and strategic treatment planning for affected patients. This study underlines the necessity of personalized surveillance to improve outcomes. #CancerSurvivorship #PrecisionMedicine #HealthcareInnovation

Hi Elliot Zeelander! Great question. What does Yunu do? We ensure imaging measurements of solid tumors are tracked accurately on clinical trials. These measurements are critically important for 90% of all oncology clinical trials. It saves 80% of imaging work for study staff and 50% for radiologists. Why do cancer centers buy it? It saves money in year 1. It reduces errors from as high as 50% to around 2-3%. It ensures sites have audit ready results to be compliant for regulators and impressively accurate for sponsors. Yunu achieved this by building a pure cloud-based workflow, measurement, and data management system from the ground up to keep the oncologists, research study staff, and radiology readers clicking seamlessly. A big topic for investors is cross site resource sharing, collaboration, and co-operatives. With Yunu, anyone can be anywhere and perform their work in a secure and compliant manner. Yunu is changing the game for sites, CROs, and sponsors.

Join Dr. Sandeep Nayak, a renowned oncologist, as he delves into the intricate procedure of hemithyroidectomy for thyroid cancer. In this comprehensive video, Dr. Nayak explains the indications, benefits, and potential risks associated with the surgery. Gain insights into the latest surgical techniques, post-operative care, and what patients can expect during their recovery journey. Whether you're a medical professional or someone seeking information about thyroid cancer treatments, this video is an invaluable resource. https://lnkd.in/dQ4XBDaq #DrSandeepNayak #ThyroidCancer #Hemithyroidectomy #ThyroidSurgery #CancerTreatment #Oncology #CancerCare #ThyroidHealth #SurgicalOncology #Thyroidectomy #MedicalEducation #HealthAwareness #CancerAwareness #ThyroidDisease #PatientCare #Surgery #ThyroidCancerTreatment #CancerResearch #ThyroidGland #MedicalVideo

Oral Cancer Treatment Global Market Report 2024 . The oral cancer treatment market size has grown strongly in recent years. It will grow from $1.9 billion in 2023 to $2.04 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to interdisciplinary treatment approaches, screening programs implementation, improvements in palliative care, reconstructive surgery innovations, clinical trial discoveries. . The oral cancer treatment market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%.  . Read More @ https://lnkd.in/gzZ84pBn . #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #GlobalMarketModel

Those of us at #MNCCTN often talk about how the "standard of care" today is all the result of clinical trials. But what does that mean? Standard of care is the usual treatment given to participants for an illness. For cancer, standard of care could be chemotherapy, immunotherapy, hormone therapy, radiation, surgery, and more (or a combination of multiple of these). All new treatments and medications must undergo clinical trials. This means that today's researched treatment could be the standard of care in a few years if shown to be safe, effective, and better than existing treatments! Check out this definition and other clinical trial terms in the MRCT Center Glossary: https://lnkd.in/g3Z9N3ND #MNCCTN #research #clinicalresearch #clinicaltrials #cancerresearch #cancer #health #healthliteracy #oncology #TrialTermsTuesday